{"id":73013,"date":"2026-05-01T20:38:41","date_gmt":"2026-05-01T20:38:41","guid":{"rendered":"https:\/\/www.europesays.com\/dk\/73013\/"},"modified":"2026-05-01T20:38:41","modified_gmt":"2026-05-01T20:38:41","slug":"canada-approves-second-generic-version-of-ozempic","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/dk\/73013\/","title":{"rendered":"Canada approves second generic version of Ozempic"},"content":{"rendered":"\n<p class=\"yf-1fy9kyt\">OTTAWA, May 1 (Reuters) &#8211; The \u200cCanadian \u200chealth regulator said \u200bon Friday that it had \u200capproved Canada-based \u2060Apotex&#8217;s generic version \u2060of semaglutide, making \u200bit \u200bthe \u200bsecond copycat \u200cversion of Danish drugmaker Novo Nordisk&#8217;s blockbuster \u200cdiabetes \u200bdrug \u200bOzempic \u200bauthorized in \u200cthe country.<\/p>\n<p class=\"yf-1fy9kyt\">(Reporting by \u200bIsmail \u200bShakil and \u200bRyan \u200cPatrick Jones; Editing \u200bby Caitlin \u200bWebber)<\/p>\n","protected":false},"excerpt":{"rendered":"OTTAWA, May 1 (Reuters) &#8211; The \u200cCanadian \u200chealth regulator said \u200bon Friday that it had \u200capproved Canada-based \u2060Apotex&#8217;s&hellip;\n","protected":false},"author":2,"featured_media":73014,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[271],"tags":[38484,272,39554],"class_list":["post-73013","post","type-post","status-publish","format-standard","has-post-thumbnail","category-novo-nordisk","tag-generic-version","tag-novo-nordisk","tag-ryan-patrick-jones"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@dk\/116501250477272078","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/73013","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/comments?post=73013"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/73013\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media\/73014"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media?parent=73013"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/categories?post=73013"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/tags?post=73013"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}